A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Clinical trial NCT01037907 · TERMINATED
Trial details
- NCT number
- NCT01037907
- Sponsor
- Boston Scientific Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.